Palpable 32 mm calcification field with intermediate-grade DCIS on 14-gauge core — upgrade, extent, axilla and adjuvant plan

Station brief

She is 47, her disease is palpable, and her core was taken with the device most prone to underestimation. Her lesion stacks four upgrade predictors — 14-gauge sampling, intermediate grade, 32 mm span, palpability — against a pooled one-in-four invasion rate at excision, so the first consent is about the diagnosis changing, not the operation.^[10]

Expected management

• Consent the upgrade with her predictors named. One in four core DCIS diagnoses (25.9%) prove invasive at excision; 14-gauge automated sampling, grade, size over 20 mm and palpability each raise her above the average — and Alberta upstaging ran 23%, predicted only by size.^[10][22]
• Judge extent before promising conservation. A 32 mm palpable field may exceed breast-conserving geometry; size predicts mastectomy (37.6% in Alberta) — offer conservation only if 2 mm clearance with acceptable cosmesis is credible, otherwise plan mastectomy without apologising for it.^[22][9]
• Set the margin standard explicitly. Excise to 2 mm with whole-breast irradiation in view: negative margins halve recurrence against ink on DCIS, wider clearance adds nothing, and sub-2 mm negativity alone never mandates mastectomy — clinical judgment, documented.^[9]
• Decide the axilla by operation. Conservation: no sentinel biopsy, with delayed staging retrievable if invasion appears (2% metastases in pure DCIS). Mastectomy: offer sentinel biopsy at the same operation — the mapping window closes with the breast.^[11][12]
• Counsel adjuvants with trial numbers. Lumpectomy plus 50 Gy cut invasive ipsilateral tumours 13.4 to 3.9% (B-17, all subgroups); tamoxifen 20 mg daily for 5 years cut 5-year events 8.2 versus 13.4% (B-24, holding with involved margins and comedonecrosis) — local control in both cases, survival in neither.^[1][2]
• Set follow-up by grade and time. Intermediate grade sits between the 76-month high-grade and 131-month low-grade invasive clocks, with recurrence at 180 months doubling that at 60 — annual mammography for a decade, with the explicit warning that short follow-up misses invasive events.^[18]

Examiner probes

• What changes if the core were vacuum-assisted 11-gauge with 12 cores of calcifications only, low grade, 8 mm, non-palpable? (Upgrade probability falls on every predictor — smaller excision, same 2 mm standard, stronger conservation case, same axillary rule.)^[10][9]
• What changes if excision shows 6 mm of invasion with a positive sentinel node? (She leaves the DCIS pathway for the invasive breast-cancer topic — stage, receptors, systemic plan — referred, never improvised here.)^[10]
• What changes if she is 47 with a strong family history and asks about bilateral mastectomy? (Contralateral cancers run ~10% at 15 years regardless of ipsilateral treatment, 7.3% with tamoxifen — the opposite breast earns surveillance and risk assessment, not reflex surgery.)^[19]